Table 3 Altered metabolites between healthy participants from United Kingdom (n = 22) and Thailand (n = 20).

From: Mapping of population disparities in the cholangiocarcinoma urinary metabolome

m/z

RT

Tentative assignment

Adduct

VIP

Trend in UK-Healthy

p-value

FC

Identification

144.102

0.58

Proline betaine

M + H

17

 < 0.001

4.86

b

160.133

0.70

Unknown

 

5.1

 < 0.001

3.63

d

229.155

0.99

Isoleucyl proline

M + H

10.4

 < 0.001

1.81

b

137.046

1.11

Hypoxanthine

M + H

6.1

0.003

1.55

b

166.073

1.17

7-Methylguanine

M + H

4.1

NS

1.35

b

167.057

2.38

7-Methylxanthine

M + H

5.3

 < 0.001

5.84

b

180.088

2.88

Fructosamine

M + H

4.3

0.006

1.44

b

126.092

3.01

Unknown

 

6.4

 < 0.001

2.58

d

181.073

3.18

Paraxanthine

M + H

4.7

NS

2.01

b

105.033

3.82

Hippurate

M + H

3.9

NS

1.2

a

287.207

4.93

Acylcarnitine (C8:1)

M + H

7

 < 0.001

7.74

b

312.217

5.17

2-trans,4-cis-Decadienoylcarnitine

M + H

5.2

NS

3.62

b

310.202

5.35

Acylcarnitine (C10:3)

M + H

11.2

 < 0.001

6.81

b

314.233

5.78

Decenoylcarnitine (C10:1)

M + H

5.3

0.021

2.18

b

243.061

0.85

Uridine/pseudouridine

M-H

3.8

 < 0.001

 − 1.58

b

191.018

0.96

Isocitrate

M-H

8.0

NS

1.25

b

191.018

1.07

Citrate

M-H

7.1

NS

1.42

a

188.001

1.61

2-aminophenol sulfate

M-H

3.9

 < 0.001

8.19

b

194.045

3.17

N-Salicyluric acid

M-H

4.2

NS

 − 1.48

c

181.049

3.29

Dihydrocaffeic acid

M-H

4.7

NS

 − 1.92

b

261.006

3.65

Dihydrocaffeic acid-3-O-sulfate

M-H

4.8

NS

 − 4.34

b

263.102

3.84

Phenylacetylglutamine

M-H

4.3

NS

1.16

b

245.012

3.93

Vanillin 4-sulfate

M-H

6.1

NS

 − 2.59

b

287.022

4.14

DHPV O-sulfate

M-H

4.8

NS

1.73

b

345.154

4.89

Steroid glucuronide

 

3.7

NS

3.33

c

269.149

4.91

Unknown

 

6.7

 < 0.001

3.89

c

329.16

5.63

Steroid glucuronide

 

3.6

0.012

 − 6.50

c

367.157

6.48

Unidentified steroid

 

5.1

NS

4.75

c

  1. FC fold change; m/z mass–charge ratio; RT retention time; VIP variable importance in projection score Level of metabolite identification: (a) identified compound; (b) putatively annotated compound; (c) putatively characterised compound class;
  2. and (d) unknown False discovery rate (FDR) adjusted p-value (or q-value).